BRPI0716391A2 - método de previsão de metástase distante de câncer de mama primário nódulo linfático-negativo usando análise de expressão gênica de via biloógica - Google Patents

método de previsão de metástase distante de câncer de mama primário nódulo linfático-negativo usando análise de expressão gênica de via biloógica

Info

Publication number
BRPI0716391A2
BRPI0716391A2 BRPI0716391A BRPI0716391A BRPI0716391A2 BR PI0716391 A2 BRPI0716391 A2 BR PI0716391A2 BR PI0716391 A BRPI0716391 A BR PI0716391A BR PI0716391 A BRPI0716391 A BR PI0716391A BR PI0716391 A2 BRPI0716391 A2 BR PI0716391A2
Authority
BR
Brazil
Prior art keywords
bile
logical
gene expression
breast cancer
prediction method
Prior art date
Application number
BRPI0716391A
Other languages
English (en)
Inventor
X Yu Jack
Zhang Yi
Wang Yixin
Original Assignee
Veridex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex Llc filed Critical Veridex Llc
Publication of BRPI0716391A2 publication Critical patent/BRPI0716391A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BRPI0716391A 2006-09-05 2007-09-05 método de previsão de metástase distante de câncer de mama primário nódulo linfático-negativo usando análise de expressão gênica de via biloógica BRPI0716391A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84221206P 2006-09-05 2006-09-05
PCT/US2007/077593 WO2008030845A2 (en) 2006-09-05 2007-09-05 Methods of predicting distant metastasis of lymph node-negative primary breast cancer using biological pathway gene expression analysis

Publications (1)

Publication Number Publication Date
BRPI0716391A2 true BRPI0716391A2 (pt) 2017-01-31

Family

ID=39157990

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0716391A BRPI0716391A2 (pt) 2006-09-05 2007-09-05 método de previsão de metástase distante de câncer de mama primário nódulo linfático-negativo usando análise de expressão gênica de via biloógica

Country Status (8)

Country Link
US (1) US20080182246A1 (pt)
EP (1) EP2061905A4 (pt)
JP (1) JP2010502227A (pt)
CN (1) CN101573453A (pt)
BR (1) BRPI0716391A2 (pt)
CA (1) CA2662501A1 (pt)
MX (1) MX2009002535A (pt)
WO (1) WO2008030845A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9863952B2 (en) * 2008-03-31 2018-01-09 Council Of Scientific & Industrial Research Method for the diagnosis of higher- and lower-grade astrocytoma using biomarkers and diagnostic kit thereof
EP2108705A1 (en) * 2008-04-08 2009-10-14 Universität Duisburg-Essen Method for analysing the epigenetic status of the HtrA 1 gene in a biological sample
GB0808668D0 (en) * 2008-05-13 2008-06-18 Univ Aberdeen Materials and methods relating to a G-protein coupled receptor
US8519104B2 (en) 2009-11-12 2013-08-27 Alper Biotech, Llc Monoclonal antibodies against GMF-B antigens, and uses therefor
AU2011239707A1 (en) * 2010-04-13 2012-11-08 The Trustees Of Columbia University In The City Of New York Biomarkers based on a multi-cancer invasion-associated mechanism
US9857374B2 (en) 2010-08-13 2018-01-02 Arizona Board of Regents, a body corporate acting for and on behalf of Arizona State University Biomarkers for the early detection of breast cancer
EP2463658A1 (en) * 2010-12-13 2012-06-13 Université de Liège Biomarkers, uses of biomarkers and a method of identifying biomarkers
EP2707720B1 (en) * 2011-05-11 2018-03-14 Alper Biotech, Llc Diagnosis and prognosis of triple negative breast and ovarian cancer
RU2544094C2 (ru) * 2012-12-29 2015-03-10 Общество с ограниченной ответственностью "Митрель-Люмитек" Способ интраоперационной визуализации патологических очагов
KR101672531B1 (ko) * 2013-04-18 2016-11-17 주식회사 젠큐릭스 조기 유방암 예후 예측 진단용 유전자 마커 및 이의 용도
US20160138113A1 (en) * 2013-06-19 2016-05-19 Memorial Sloan-Kettering Cancer Center Methods and compositions for the diagnosis, prognosis and treatment of brain metastasis
TWI615472B (zh) * 2013-09-18 2018-02-21 Nat Defense Medical Center 預測乳癌復發之基因標記及方法
SG10201807838SA (en) * 2014-03-11 2018-10-30 Council Queensland Inst Medical Res Determining cancer aggressiveness, prognosis and responsiveness to treatment
US20160026759A1 (en) * 2014-07-22 2016-01-28 Yourgene Bioscience Detecting Chromosomal Aneuploidy
CN113899902B (zh) * 2020-06-22 2024-10-29 上海科技大学 一种酪氨酸磷酸酶底物鉴定方法
CN113151355A (zh) * 2021-04-01 2021-07-23 吉林省农业科学院 鸡strn3基因3’utr的双荧光素酶报告基因载体及其构建方法与应用
CN114034866A (zh) * 2021-11-29 2022-02-11 湖州市中心医院 乳腺癌诊断标志物及其应用
CN114452391B (zh) * 2022-01-28 2023-08-25 深圳市泰尔康生物医药科技有限公司 Cdk16作为靶标在制备用于治疗三阴性乳腺癌的药物中的应用
CN121955382B (zh) * 2026-03-31 2026-06-19 上海交通大学医学院附属仁济医院 一种用于肠道结外自然杀伤/t细胞淋巴瘤鉴别诊断的蛋白标志物及其用途

Also Published As

Publication number Publication date
CN101573453A (zh) 2009-11-04
WO2008030845A2 (en) 2008-03-13
EP2061905A2 (en) 2009-05-27
WO2008030845A3 (en) 2008-11-27
US20080182246A1 (en) 2008-07-31
MX2009002535A (es) 2009-03-20
WO2008030845A8 (en) 2009-11-05
EP2061905A4 (en) 2009-09-30
JP2010502227A (ja) 2010-01-28
CA2662501A1 (en) 2008-03-13

Similar Documents

Publication Publication Date Title
IL276488A (en) Method of predicting breast cancer prognosis
CY2020039I2 (el) Νεα anti-cd38 αντισωματα για τη θεραπευτικη αγωγη καρκινου
EP2158332A4 (en) FORECASTING FOR MELANOMA
PL2297359T3 (pl) Profile ekspresji genów do przewidywania skutków raka piersi
SI2027470T1 (sl) Analiza kroĺ˝eäśe tumorske celice
EP2598659A4 (en) METHOD FOR THE USE OF GENE EXPRESSION FOR DETERMINING THE PROGNOSIS OF PROSTATE CANCER
DK2115472T3 (da) Cancerbiomarkører
IL200181A0 (en) Method for predicting the occurrence of metastasis in breast cancer patients
EP4219765C0 (en) PROGNOSIS OF PROSTATE CANCER USING BIOMARKERS
EP2061899A4 (en) BIOMARKERS FOR PROSTATE CANCER AND METHOD FOR THEIR USE
PL2733492T3 (pl) Sposób wykrywania nowotworów
BRPI1006075A2 (pt) biomarcadores de cancer
EP2340555A4 (en) PROBE BLOCK ARRANGEMENT
DK3101141T3 (da) Fremgangsmåde til methyleringsanalyse
EP2171453A4 (en) OVARIAN CANCER-FORECAST MARKER
EP2691547A4 (en) GENE EXPRESSION PREDICTORS FOR CANCER PROSPECTS
EP2831281A4 (en) MOLECULAR MARKERS FOR THE PROGNOSTIC PREDICTION OF PROSTATE CANCER, METHOD AND KIT THEREFOR
EP2207037A4 (en) CANCER DETECTION METHOD
IL200197A (en) A method for assessing prostate cancer risk by determining genetic variants
WO2008030845A3 (en) Methods of predicting distant metastasis of lymph node-negative primary breast cancer using biological pathway gene expression analysis
IL205347A0 (en) Process for predicting the prognosis of squamous cell lung cancer
EP2354790A4 (en) METHOD FOR DETECTING PROSTATE CANCER
EP2406728A4 (en) METHOD FOR IDENTIFYING, PREDICTING AND FORECASTING TUMORAGGRESSIVITY
PL2024748T3 (pl) Przeciwciała monoklonalne przeciw aneksynie A3 do wykrywania raka gruczołu krokowego
UA114478C2 (uk) Антитіло, яке специфічно зв'язується з bst1

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]